Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of FIBROGEN INC from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Fibrogen Inc quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from 2016 to Q1 2025.
  • Fibrogen Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Mar 2025 was $4.02M.
  • Fibrogen Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was -$11.5M, a 72.6% increase from 2023.
  • Fibrogen Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$42M, a 171% decline from 2022.
  • Fibrogen Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was -$15.5M, a 96.9% increase from 2021.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

FIBROGEN INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4.02M +$12M 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q1 2024 -$7.95M -$40.8M -124% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q1 2023 $32.9M +$18.2M +124% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q1 2022 $14.7M +$260M 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q1 2021 -$245M -$240M -5104% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q1 2020 -$4.71M +$2.88M +38% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q1 2019 -$7.59M +$7.07M +48.2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q1 2018 -$14.7M 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019

FIBROGEN INC Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$11.5M +$30.5M +72.6% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 -$42M -$26.5M -171% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 -$15.5M +$492M +96.9% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2024
2021 -$507M -$1.06B -192% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024
2020 $552M +$515M +1392% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023
2019 $37M +$621M 01 Jan 2019 31 Dec 2019 10-K/A 04 Mar 2022
2018 -$584M -$1.08B -217% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 $500M +$479M +2343% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020
2016 $20.5M 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.